➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Baxter
AstraZeneca
Johnson and Johnson
Colorcon
Mallinckrodt

Last Updated: June 13, 2021

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040620


Email this page to a colleague

« Back to Dashboard

NDA 040620 describes METHYLPREDNISOLONE ACETATE, which is a drug marketed by Akorn, Amneal, Sagent Pharms Inc, Sandoz Inc, Teva Pharms Usa, and Watson Labs, and is included in thirteen NDAs. It is available from seven suppliers. Additional details are available on the METHYLPREDNISOLONE ACETATE profile page.

The generic ingredient in METHYLPREDNISOLONE ACETATE is methylprednisolone acetate. There are forty drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the methylprednisolone acetate profile page.
Summary for 040620
Tradename:METHYLPREDNISOLONE ACETATE
Applicant:Teva Pharms Usa
Ingredient:methylprednisolone acetate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 040620
Suppliers and Packaging for NDA: 040620
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
METHYLPREDNISOLONE ACETATE methylprednisolone acetate INJECTABLE;INJECTION 040620 ANDA Teva Parenteral Medicines, Inc. 0703-0043 0703-0043-01 1 VIAL, MULTI-DOSE in 1 CARTON (0703-0043-01) > 5 mL in 1 VIAL, MULTI-DOSE
METHYLPREDNISOLONE ACETATE methylprednisolone acetate INJECTABLE;INJECTION 040620 ANDA Teva Parenteral Medicines, Inc. 0703-0045 0703-0045-01 1 VIAL, MULTI-DOSE in 1 CARTON (0703-0045-01) > 10 mL in 1 VIAL, MULTI-DOSE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength40MG/ML
Approval Date:Oct 27, 2006TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength80MG/ML
Approval Date:Oct 27, 2006TE:ABRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
McKesson
Baxter
Merck
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.